Page 4 - Biocon Stock

Biocon Biologics gets positive opinion from EMA for ophthalmology product

Yesafili aims to treat various visual impairments and age-related macular degeneration

Biocon shares trim most of early gains, end flat amid profit-taking

Shares of Biocon trimmed most of their early gains and ended flat on Wednesday amid profit-taking. During the early trade, the stock climbed nearly 8 per cent after the biotechnology major's consolidated net profit increased 31 per cent for the March quarter. The stock gained 7.12 per cent to Rs 259.50 during the day on the BSE but failed to hold on to the momentum and ended flat. It settled at Rs 243 apiece, marginally up 0.31 pe cent. On the NSE, the stock settled at Rs 242.95 per share, a gain of 0.33 per cent after rallying 7.61 per cent to Rs 260.60 during the day. In volume terms, 18.97 lakh shares of the company were traded on the BSE and over 1.77 crore shares on the NSE during the day. On Tuesday, Biocon said its consolidated net profit increased 31 per cent to Rs 313 crore for the March quarter on the back of robust sales. The company had reported a net profit of Rs 239 crore in January-March 2021-22. Total revenue increased to Rs 3,929 crore in the fourth quarter as a

Nifty Pharma dips to 7-mth low; bears may gain control if breaks 52-wk low

Barring Sun Pharmaceutical Industries, which is anticipated to rally up to 10 per cent; other stocks indicate weak bias, as per technical charts

Viatris deal-related expenses drag Biocon's Q3 net into Rs 42 cr loss

This, even as revenues rise 36% and Ebitda is up 35%

MSCI revision: CG Power, Bank Baroda look bullish on charts; avoid Biocon

Biocon share may slip up to 21 per cent if breaks 52-week low

Biocon sells 9.96% stake in contract research firm Syngene via open market

Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing

Stocks to Watch: Zomato, SBI, Adani Group, Britannia, ONGC, Gland Pharma

Stocks to Watch Today: According to reports, Zomato is likely to witness a block deal on Wednesday.

Biocon Q2 results: Net profit declines 10% to Rs 168 crore, revenue up 26%

Biocon's core Ebitda came in at Rs 816 crore, up 34 per cent

Stocks to watch: Biocon, SpiceJet, PNB, NTPC, Ashok Leyland, Coffee Day

Stocks to watch today: Biocon received 11 observations in Form 483 for their Bengaluru and Mayalsia facilities from the USFDA; Ashok Leyland won orders from major fleets for 1,400 school buses in UAE.

Sensex, Nifty end flat in choppy session; metals, auto, IT packs slip most

Stock market LIVE updates: The broader markets suffered more losses than the frontline indices. The BSE MidCap and SmallCap indices shed 0.5 and 0.7 per cent, respectively.

Stocks to watch: Tata Steel, HDFC, Jet Airways, JSW Steel, Biocon, PVR

Stocks to watch today: HDFC, slated to merge with HDFC Bank, raised Rs 4,000 crore through a paper with a maturity of 21 months; Jet Airways plans to lease 6 to 8 planes as part of re-launch.

Sensex snaps 4-day winning run, slips 150 pts; RIL gains 2%, Oil India 4.5%

CLOSING BELL: The Nifty IT, Bank, and FMCG indices dropped over 1 per cent each

Sensex gains for 3rd day, rises 433pts; Nifty holds 15,800; Zomato falls 6%

CLOSING BELL: Sectorally, the broad-based rally saw the Nifty Auto index ending with 2-per cent gain, and the Nifty Metal index with 1.6-per cent rally

Zomato, Dish TV, Biocon: Trading strategies for buzzing stocks of the day

Shares of Zomato face stiff resistance at Rs 78, while the downside support stays at Rs 60

Biocon slips 4% despite arm denying bribery charges

At 10:26 AM, the stock of Biocon was down 3 per cent at Rs 316.10, as compared to 1 per cent decline in the S&P BSE Sensex

Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results

Stocks to watch: Nazara Tech, DRL, Adani Transmission, JSW Steel, Biocon

Pharma major Dr Reddy's Laboratories (DRL) expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said

GMM Pfaudler, IDBI Bank: 14 Nifty500 stocks have surged above their 200-DMA

Analysts prefer stocks trading above the 200-DMA, since they tend to perform better in a trending market. Risk management, hence, becomes comparatively easier

Biocon tanks 10% on lower-than-expected December quarter results

Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down as the MD of Biocon Biologics

Stocks to watch: Wipro, 3i Infotech, Biocon, SBI Life, AU Small Finance

3i Infotech Ltd has entered into definitive agreements to sell its software products business to the funds advised by Apax Partners for Rs 1,000 crore